1 Min Read
June 12 (Reuters) - Numerate Inc:
* Numerate and Takeda enter agreement to generate novel clinical candidates using AI-driven drug discovery Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.